Patents by Inventor Himisha Beltran

Himisha Beltran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR IDENTIFYING CASTRATION RESISTANT NEUROENDOCRINE PROSTATE CANCER
    Publication number: 20230105008
    Abstract: The present invention is based on the identification of castration resistant neuroendocrine prostate cancer (CRPC-NE) features in the circulation, and relates to methods and compositions of identifying CRPC-NE patients by detecting these features.
    Type: Application
    Filed: February 8, 2021
    Publication date: April 6, 2023
    Inventors: Himisha Beltran, Francesca Demichelis, Gian Marco Franceschini, Alessandro Romanel
  • Molecular subtyping, prognosis and treatment of prostate cancer
    Patent number: 9568483
    Abstract: Disclosed herein are new prognostic molecular markers for prostate cancer. More specifically, the invention has identified that overexpression or amplification of at least one of AURKA or MYCN define a distinct subgroup of prostate cancer that is predisposed to the development of lethal NEPC, who will benefit from early intervention.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: February 14, 2017
    Assignee: CORNELL UNIVERSITY
    Inventors: Mark A. Rubin, Himisha Beltran
  • MOLECULAR SUBTYPING, PROGNOSIS AND TREATMENT OF PROSTATE CANCER
    Publication number: 20140037647
    Abstract: Disclosed herein are new prognostic molecular markers for prostate cancer. More specifically, the invention has identified that overexpression or amplification of at least one of AURKA or MYCN define a distinct subgroup of prostate cancer that is predisposed to the development of lethal NEPC, who will benefit from early intervention.
    Type: Application
    Filed: March 28, 2012
    Publication date: February 6, 2014
    Applicant: CORNELL UNIVERSITY
    Inventors: Mark A. Rubin, Himisha Beltran